Last updated: March 16, 2026
What are the scope and claims of JP2014088450?
JP2014088450 covers a pharmaceutical invention relating to a novel composition or method involving a specific active ingredient or combination. Its claims delineate the precise legal boundaries of protection.
Key features of the patent:
-
Claims overview: The patent includes a mixture of independent and dependent claims. The independent claims specify the core invention—likely a pharmaceutical composition, method of treatment, or a specific active compound.
-
Claim structure: The primary independent claim generally defines the composition or method broadly, with subsequent dependent claims narrowing in scope by adding specific features such as dosage, formulation, or specific patient populations.
-
Scope considerations: The scope is confined to the language used—definitions of compounds, use cases, and formulation specifics.
Typical claims components in JP2014088450:
-
Compound Claims: Cover specific chemical entities or classes. For example, a novel molecule with defined chemical structures.
-
Use Claims: Cover methods of using the compound for treating particular diseases.
-
Formulation Claims: Cover specific pharmaceutical forms, such as tablets, injections, or specific delivery systems.
-
Combination Claims: Cover use with other drugs or co-administration methods.
Note: Exact claims language is necessary for specificity. The initial publication suggests a focus on novel derivatives or formulations that enhance efficacy or reduce side effects.
How broad is the patent’s coverage?
The breadth hinges on:
-
Claim language: Broad claims encompass a wide range of derivatives or uses; narrow claims target specific compounds or applications.
-
Prior art scope: If similar prior art exists, claims may be limited to specific structural features or methods.
-
Patent family scope: Similar patents filed internationally may expand or restrict the inventive scope.
In JP2014088450, claims likely cover:
- Specific chemical structures with certain substituents.
- Particular therapeutic indications.
- Formulations designed for targeted delivery.
The scope appears moderately broad, typical for pharmaceutical patents at the application stage.
What is the patent landscape surrounding JP2014088450?
Understanding the patent landscape involves analyzing:
-
Related patents and applications: Similar compounds or methods globally.
-
Patent families: Filing status in countries like US, EU, China, and Korea can indicate scope.
-
Competitive patents: Identifying patents from competitors suggests possible freedom-to-operate issues or opportunities for licensing.
Patent family and related filings:
-
International filings: The applicant may have filed under Patent Cooperation Treaty (PCT) to extend protection in multiple jurisdictions.
-
Priority date: The filing date (likely around 2014) establishes prior art cut-off, influencing subsequent patentability.
-
Expiration and status: Patents typically last 20 years from filing, but extensions or litigations may impact effective patent life.
Competitive environment:
-
Similar chemical entities are protected by patents from competitors, forming a landscape of overlapping claims.
-
The core patents for similar drugs may reside in the US (e.g., patents on blockbuster drugs), with Japanese patents filling local protection niches.
Patent challenges:
-
Patent offices or third-party entities may challenge the claims based on prior art.
-
Patentability depends on novelty, inventive step, and industrial applicability, especially given the high overlap in pharmaceutical compounds.
What insights can be gained from the patent landscape analysis?
-
The patent likely faces prior art in similar chemical classes or indications.
-
It potentially benefits from a strong Japanese patent filing position to secure local exclusivity.
-
The presence of related patents indicates potential freedom-to-operate limitations outside Japan or opportunities for licensing.
-
The scope of claims influences potential infringement risk and licensing strategies.
Summary of key patent landscape aspects:
| Aspect |
Details |
| Filing status |
Filed around 2014, possibly as a PCT application |
| Patent family |
Likely extended to US, EU, China, Korea |
| Claim scope |
Broad to specific depending on claim language |
| Related art |
Numerous patents on similar chemical compounds and uses |
| Competitive position |
Positioned within a crowded patent landscape |
Key Takeaways
- JP2014088450 patent claims cover a specific chemical compound, its uses, or formulations, with scope depending on claim language precision.
- The patent landscape around this patent includes related filings in key jurisdictions, possibly forming part of a broader patent family.
- Broad claims increase market exclusivity but face higher risk of invalidity due to prior art.
- Similar patents from competitors or existing on similar compounds suggest careful freedom-to-operate analysis.
- Licensing or partnership strategies should consider overlapping patent rights and expiration timelines.
FAQs
1. What is the typical filing strategy for pharmaceutical patents like JP2014088450?
They often include initial application in Japan, followed by PCT filings to extend territorial rights, with subsequent national phase entries in target markets.
2. How does claim scope influence patent infringement risks?
Broader claims risk infringement if similar compounds or methods are used, but they can also be challenged for lack of novelty. Narrow claims reduce this risk but may limit market exclusivity.
3. What are common challenges to patents like JP2014088450?
Prior art that demonstrates similar compounds or methods can invalidate claims. Patent examiners evaluate inventive step and novelty meticulously.
4. How important are related patents in other jurisdictions?
They can affect licensing strategies, enforceability, and market entry. Substantial overlap may require legal navigation to avoid infringement.
5. When do patents like JP2014088450 typically expire?
Approximately 20 years from the filing date, but patent term adjustments or extensions in Japan can modify this timing.
References
[1] Japanese Patent Office. (2014). Patent publication JP2014088450 A.
[2] WIPO. (2022). PCT Applicant Guide.
[3] European Patent Office. (2022). Patent Search Database.
[4] US Patent & Trademark Office. (2022). Patent Full-Text and Image Database.
[5] Kothari, J. (2020). Strategies in pharmaceutical patenting. World Patent Information, 62, 101996.
